Engagement of T-cell receptors (TCRs) on immature thymocytes by self-antigen-major histocompatibility complexes causes the death of self-reactive thymocytes via apoptosis, a phenomenon that establishes T-cell tolerance.
Similarly, treatment of thymocytes with anti-TCR antibodies leads to TCR-mediated apoptosis, which can also be induced in T-cell hybridomas. TCR-mediated apoptosis in immature thymocytes and T-cell hybridomas requires the expression of a new set of genes. In particular, it has recently been shown that the expression of Nur77, a transcription factor which is a member of the steroid/thyroid receptor superfamil, is required for TCR-mediated apoptosis in T-cell hybridomas and perhaps in thymocytes. Cyclosporin A (CsA), an immunosuppressive drug, has been shown to interfere with clonal deletion of self-reactive T cells in vivo, partly by blocking TCR-mediated apoptosis. We report here that CsA inhibits the TCR-mediated activation of Nur77 protein in T-cell hybridomas by blocking the DNA binding activity of Nur77 protein rather than its de novo synthesis. We also show that CsA mediates its negative effects on the Nur77 DNA binding activity through the N-terminal region of the protein. This complete inhibition of Nur77 protein DNA binding activity may explain how CsA interferes with TCR-mediated apoptosis.
The peripheral T-cell repertoire is determined by the positive and negative selection of immature thymocytes during development in the thymus (1) (2) (3) (4) . During development, most self-reactive immature thymocytes are eliminated by negative selection (clonal deletion) to establish immunological selftolerance (2) (3) (4) . This process of clonal deletion is thought to be mediated by apoptosis (2) (3) (4) . Self-reactive thymocytes are therefore induced to undergo apoptosis upon engagement of their T-cell receptor (TCR) by tolerogenic antigen-major histocompatibility complex (MHC) complexes (2) (3) (4) . Immature thymocytes can also be induced to undergo apoptosis by treatment of anti-TCR antibodies (5) (6) (7) (8) (9) (10) . Similar treatment also induces apoptotic death in T-cell hybridomas (5) (6) (7) (8) (9) (10) . In both thymocytes and T-cell hybridomas, TCR-mediated apoptosis requires the expression of-new genes and is associated with intracellular calcium mobilization and genome digestion (5) (6) (7) (8) (9) (10) . Because of these similar properties, T-cell hybridomas have provided a useful in vitro model for the study of TCRmediated apoptosis of thymocytes (5) (6) (7) (8) (9) (10) .
The crosslinking of TCR by antigen-MHC complexes or anti-TCR antibodies induces complex alterations in gene expression (11, 12) . Analysis of the patterns of RNA expression during apoptosis of immature thymocytes or T-cell hybridomas has revealed the induction of several new genes (11) (12) (13) (14) (15) . Only a few genes, however, have been shown to be involved in TCR-mediated apoptosis (13) (14) (15) . Of those, the expression of c-myc has been implicated in the induction of apoptosis in T-cell hybridomas via TCR (13) . It has also been shown that the expression of Nur77, a transcription factor which is a member of the steroid/thyroid receptor superfamily, is required for TCR-mediated apoptosis in T-cell hybridomas (14, 15) . Since c-myc and Nur77 are involved in the transcriptional control of their respective target genes, it has been presumed that the expression of these genes will be responsible for induction of as yet unidentified genes mediating cell death.
Cyclosporin A (CsA) is an immunosuppressive drug that has been widely used in transplantation medicine (16) . However, CsA also induces T-cell-mediated autoimmunity in some cases (16) . It has been reasoned that CsA induces autoimmune disease by interfering with the clonal deletion of self-reactive T cells, partly by blocking TCR-mediated apoptosis (17, 18) . The interference of TCR-mediated apoptosis by CsA has also been shown in T-cell hybridomas (19, 20) . In the current study, we examine whether this interference involves the expression of Nur77 and show that CsA indeed completely abolishes the DNA binding activity of Nur77 protein, which is an essential component of transcriptional activation in TCR-stimulated T-cell hybridomas.
MATERIALS AND METHODS
Induction of Apoptosis and DNA Fragmentation Assay. DNA fragmentation was quantified by measuring the amount of labeled DNA bound to fiberglass filters as described (21) . In brief, DO11-10.24 T-cell hybridomas were labeled with [3H]thymidine (4 ,uCi/ml; 1 Ci = 37 GBq) for 2 h. After extensive washing, 50,000 cells were plated into 96-well microtiter plates coated with anti-TCR antibody H57-597 at the concentrations indicated (22) . Different doses of CsA (Sandoz Pharmaceutical) were added to the culture medium. After 16 h of culture, the cells were lysed and harvested onto a fiberglass filter, to which only the intact chromatin adheres (21) . DNA fragmentation was calculated as follows: % DNA fragmentation = (S -E)/S x 100, where S is the amount of labeled DNA bound to filters from cells in control unstimulated medium and E is the amount of labeled DNA bound to filters from cells under different experimental conditions.
Transfection. The N-terminal deletion form of the Nur77 gene was isolated from the plasmid pSGA4 601T (23) and cloned into a eukaryotic expression vector, pH,3APr-1 (24) , to generate pN77D. The plasmid, pN77D, was transfected into T-cell hybridomas by electroporation using a Gene Pulser transfection apparatus (Bio-Rad). Transfectants were selected by their G418 resistance as described (25) . Gel-Shift Assay. Gel-shift assays were performed as described (23) . Cells were stimulated with anti-TCR antibody (on plates coated with 10 ,ug of H57-597 per ml overnight) for [4] [5] [6] h with different doses of CsA, and nuclear extracts were tK.Y. and J.-W.C. contributed equally to this work. §To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. prepared as described (23) . The sequences of oligonucleotide probes of Nur77 response element and GT box were 5'-GAGTTTTAAAAGGTCATGCTCAATTT-3' and 5'-GAGGTGGGTGGAGTTTCGCG-3', respectively (14, 26) . All of the experiments were done in the presence and absence of specific, unlabeled competitor oligonucleotides, and only those experiments done in the absence of specific competitor probes are shown.
RNA and Protein Analysis. Total RNA purified from unstimulated and stimulated cells was analyzed by Northern blotting as described (27) . Nur77 mRNA was detected by using a Nur77 cDNA probe (28) , and interleukin 2 (IL-2) mRNA was detected with an IL-2 cDNA probe (29) . After analysis, the filter was washed and hybridized with a glyceraldehyde-3-phosphate dehydrogenase probe (30) to control the amounts of mRNA loaded. All Northern analysis was quantified with a Phosphorlmager (Molecular Dynamics).
Western blot analysis was done as described (31) . In brief, cells were lysed in RIPA buffer (150 mM NaCl/50 mM Tris HCl, pH 8.0/1% Nonidet P-40/0.5% sodium deoxycholate/0.1% SDS) containing phenylmethylsulfonyl fluoride, 1% aprotinin, and 10 ,ug of leupeptin per ml. Lysates were precleared with protein A-Sepharose CL-4B (Pharmacia). Then equal amounts of protein extracts were subjected to immunoprecipitation with affinity-purified anti-Nur77 antibody (31) and protein A-Sepharose CL-4B. After extensive washing, protein-antibody-protein A-Sepharose complexes were analyzed on SDS/polyacrylamide gels followed by Western analysis with anti-Nur77 antibody and the ECL system (Amersham) as described (31) .
Phosphopeptide Mapping. Phosphopeptide mapping was done as described (31) . In brief, T-cell hybridomas were Pont/NEN) in phosphate-free RPMI 1640 medium with 10% dialyzed fetal calf serum for 2 h. T-cell hybridomas were then stimulated with anti-TCR antibody H57-597 for 2-3 h in the presence or absence of CsA. Cells were harvested and Nur77 protein was immunoprecipitated as described above. Nur77 protein was eluted from SDS/polyacrylamide gels and digested with trypsin overnight. Peptides were electrophoresed in pH 1.9 buffer on TLC plates and then chromatographed in the second dimension in phosphochromatography buffer (1-butanol/pyridine/glacial acetic acid/water, 75:50:15:60).
RESULTS AND DISCUSSION
CsA Blocks TCR-Mediated Apoptosis and Induction of Nur77 Protein Activity. T-cell hybridomas undergo apoptosis, characterized by rapid DNA fragmentation, when their TCRs are crosslinked with anti-TCR antibodies. Since CsA has been shown to block TCR-mediated apoptosis of T-cell hybridomas, we asked whether this blockage involves the expression of Nur77. As shown in Fig. la and as reported (19, 20) , DNA fragmentation in T-cell hybridomas upon TCR crosslinking was inhibited when CsA was added to the culture medium at a dose required to inhibit lymphokine production (19, 20, 32, 
33).
We then measured the amount of active Nur77 protein in the T-cell hybridomas by a gel-shift assay with an oligonucleotide probe containing the specific target sequences of Nur77 (23, 26) . When T-cell hybridomas were stimulated with anti-TCR antibody (22) , the amount of Nur77 protein activity in nuclear extracts was greatly increased as reported (14) (Fig. lb) . Nur77 protein-DNA complexes are specifically inhibited by a 50-fold excess of unlabeled probe containing Nur77 target sequences but not by nonspecific oligonucleotide probes (Fig. lb) . Preincubation of nuclear extracts with anti-Nur77 antibody also blocked the formation of Nur77 protein DNA complexes ( (26) . Nuclear extracts were prepared from control, unstimulated cells, from cells stimulated with anti-TCR antibody (Ab) H57-597 (22) , and from cells treated with anti-TCR antibody and increasing doses of CsA. (Center) Nur77 protein-DNA complexes are specifically inhibited by 50-fold excess of unlabeled probe containing Nur77 target sequences but not by nonspecific oligonucleotide probes. (Right) Preincubation of nuclear extracts with anti-Nur77 antibody (31) also blocked formation of the Nur77 protein-DNA complexes indicated. (c) The same nuclear extracts described in b were also analyzed with an oligonucleotide probe containing a GT box (14) , which detects ubiquitous Spl family proteins, to normalize for the amount of protein loaded. Spl, Spl-like protein-GT-box complexes. Intensities of specific Nur77 protein-DNA complexes and Spl-like protein-GT-box DNA complexes were quantified with a PhosphorImager (Molecular Dynamics). The -fold induction described in the text was calculated by normalizing the intensity of Nur77 protein-DNA complexes with Spl-like protein-GT-box DNA complexes. Results shown are representative of at least three independent experiments. Lane C, control cells were incubated over the same period of time without anti-TCR antibody. the amount of Nur77 protein-DNA complexes was proportionally decreased. Addition of CsA at doses required to inhibit DNA fragmentation almost completely blocked this increase ( Fig. 1 a and b) .
Since it has been previously shown that the expression of Nur77 is required for induction of apoptosis via TCR (14, 15) , the results in this study suggest that the interference of CsA in the TCR-mediated apoptosis pathway is due to its negative effects on induction of Nur77 protein activity in T-cell hybridomas.
CsA Does Not Inhibit the Induction of Nur77 mRNA and Protein. To determine how CsA abolishes the induction of Nur77 protein activity, we first tested the effect of CsA on Nur77 mRNA induction in T-cell hybridomas. When T-cell hybridomas were stimulated by TCR crosslinking, the level of Nur77 mRNA increased up to 10-fold in comparison to that in unstimulated T-cell hybridomas (Fig. 2a) . Like many immediate-early response genes, Nur77 mRNA reached its maximal level after 1 h of stimulation and diminished with time (28) (Fig. 2a) . The amount of Nur77 mRNA in TCR-stimulated T-cell hybridomas was only slightly reduced (up to 2-fold) when the cells were treated with CsA over the same time period (Fig. 2a) . The same dose of CsA in T-cell hybridomas completely blocked induction of IL-2 gene transcription as reported (32, 33) (Fig. 2a) .
Although the level of Nur77 mRNA in stimulated T-cell hybridomas in the presence of CsA was somewhat reduced, it was still 4-to 6-fold higher 2-4 h after stimulation than that in unstimulated T cells (Fig. 2a) . At the same time points, however, the Nur77 DNA binding activity, as measured by gel-shift assay, was undetectable in TCR-stimulated, CsAtreated T-cell hybridomas (Fig. 2b) .
To determine whether Nur77 mRNA indeed produced protein in the presence of CsA, we determined the amount of Nur77 protein in whole cell extracts by Western blot analysis (Fig. 3) . We analyzed the level of Nur77 protein at 2 and 4 h poststimulation, two time points at which there was a marked discrepancy between the mRNA level and DNA binding activity of Nur77 in CsA-treated cells. As previously shown, Nur77 protein migrated over a broad range due to its phosphorylation at multiple sites (23, 30) (Fig. 3) . Like Nur77 mRNA, the amount of Nur77 protein in anti-TCR-stimulated T-cell hybridomas was significantly higher than that in control cells whether or not the cells were also treated with CsA (Figs.  2a and 3 ), suggesting that CsA did not inhibit the translation of Nur77 mRNA or the stability of the protein.
The DNA binding activity of Nur77 protein described above ( Figs. 1 and 2 ) was determined in T-cell hybridoma nuclear extracts, but the level of Nur77 protein was measured in whole cell lysates (Fig. 3) . Therefore, the discrepancy observed above between the level of Nur77 protein and its DNA binding activity might have been due to the difference in cellular localization of Nur77 (35, 36) . In particular, Nur77 is phosphorylated at Ser-354, located within a region of the protein required for DNA binding (23) . Phosphorylation of a bacterially produced Nur77 fragment at this site in vitro blocks DNA binding in a gel mobility-shift assay (37) . Furthermore, Nur77 protein induced by corticotropin treatment in the adrenal cortical cell line Y1 results in hypophosphorylation of Ser-354, correlating with the increased DNA binding activity of Nur77 in these cells (31) . The DNA binding activity of Nur77 may thus be regulated at the level of phosphorylation at Ser-354.
CsA, when bound to cyclophilin, has been shown to inhibit the ability of calcineurin to dephosphorylate its substrate (33, 38, 39) . For example, CsA inhibits dephosphorylation of cytoplasmic subunit of NF-AT (33, 38) or of the yeast transcription factor SWI5 at serine residues (39) , thereby blocking the function of these proteins. It has also been reported that calcineurin phosphatase activity is correlated with TCRmediated apoptosis of T-cell hybridomas (19) . Therefore, we tested whether CsA modulates the phosphorylation of Nur77 protein, particularly at Ser-354, in TCR-stimulated T cells.
After in vivo labeling with [32P]orthophosphate, Nur77 was immunoprecipitated and analyzed by two-dimensional phosphopeptide mapping. In T-cell hybridomas stimulated with anti-TCR antibody, the Nur77 protein is phosphorylated at a number of residues, with a pool of Nur77 being phosphorylated at Ser-354 (Fig. 4A) . In cells treated with both anti-TCR antibody and CsA, the pattern of Nur77 phosphorylation remains very similar (Fig. 4B) , suggesting that CsA treatment does not significantly affect the phosphorylation of Nur77. Importantly, the intensity of phosphopeptides corresponding to phosphorylation at Ser-354 (indicated by arrowheads) relative to other phosphopeptides appears unchanged. These results indicate that CsA treatment does not affect the relative amount of the Nur77 pool that is phosphorylated at Ser-354.
A mixing experiment (Fig. 4C) shows that the phosphopeptides identified in cells treated with or without CsA are indeed identical. Taken together, these results indicate that there is no significant difference in Nur77 phosphorylation, including phosphorylation at Ser-354, after anti-TCR treatment in the presence or absence of CsA. Therefore, the decreased DNA binding activity of Nur77 after CsA treatment is not likely to be due to hyperphosphorylation at Ser-354.
CsA, when bound to cyclophilin, also inhibits the cis-trans peptidylprolyl isomerase (rotamase) activity of cyclophilin, which may be important in protein folding (33) is not affected by CsA as described above. In addition, the amount of CsA required to inhibit Nur77 DNA binding activity is significantly higher than that required to inhibit the rotamase activity ( Fig. 1; ref. 33) .
Although no specific protein that interacts with Nur77 has been identified to date, it is tempting to speculate that the activity of Nur77 might be regulated by interacting proteins. Many other members of the steroid/thyroid receptor superfamily are also regulated in various ways by proteins that interact with them (40) . It is therefore an intriguing hypothesis that CsA might modify a protein that interacts with Nur77, thus regulating its activity. However, our data do not exclude the possibility that CsA might regulate Nur77 activity directly via a posttranslational modification other than phosphorylation at Ser-354.
CsA Mediates Its Negative Effects on the N Terminus of the Nur77 Protein Outside the DNA Binding Donmain. To determine further how CsA affects the DNA binding activity of Nur77 in T-cell hybridomas, we have transfected T-cell hybridomas with a mutant Nur77 gene, pN77D, under the control of human 1-actin promoter (24) . Nur77, like other members of the steroid receptor superfamily, contains a tripartite domain structure: a hypervariable N-terminal domain, a central zinc finger-containing DNA binding domain, and a C-terminal ligand binding domain (23,.26) . The mutant Nur77 gene, pN77D, encodes a polypeptide lacking the N-terminal transactivating domain but containing the zinc finger DNA binding domain and a potential ligand binding domain of Nur77 (23) . This mutant Nur77 protein has previously been shown to form specific DNA-protein complexes (23) .
When the transfectants expressing pN77D were treated with anti-TCR antibodies, there was a marked increase in the endogenous Nur77 protein-DNA complexes, the formation of which was completely abolished by treatment with CsA as described above (Figs. 1 and 5) . The N77D protein-DNA complexes were detected independent of anti-TCR antibody treatment since expression of the transfected gene is under the control of a constitutively active promoter (Fig. 5) . In contrast to the endogenous Nur77 protein, however, the DNA binding activity of mutant Nur77 protein was not affected by the treatment with CsA (Fig. 5) .
These results show that the DNA binding domain of Nur77 is not directly affected by CsA, and that the N-terminal part of the protein, which is deleted in the pN77D-encoded polypeptide, mediates the negative effects of CsA on the Nur77 DNA binding activity. If CsA affects Nur77 protein directly, the In this report, we show that CsA totally inhibits the DNA binding activity of Nur77 protein in TCR-stimulated T-cell hybridomas. We also show that CsA does not inhibit the induction or the translation of Nur77 mRNA, nor does it affect the stability of the protein after anti-TCR antibody stimulation. These results suggest that CsA blocks the function of Nur77 protein as a DNA binding transcription factor rather than inhibiting de novo synthesis of the protein in TCRstimulated T-cell hybridomas. Since Nur77 is a sequencespecific DNA binding transcription factor (23, 26, 31, 35) , inhibition of the DNA binding activity of Nur77 protein will abolish its ability to induce target genes. This lack of Nur77 activity may thus explain how CsA interferes with TCRmediated apoptosis.
Nur77 is an example of a transcriptional activator involved in TCR-mediated apoptosis, the activity of which is completely inhibited by CsA. The role of CsA in blocking TCR-mediated activation of T cells has been well characterized (33, 36) . For example, CsA abolishes induction of the IL-2 gene by inhibiting the nuclear translocation of cytoplasmic subunit of NF-AT, which is an essential component of transcriptional activators (33, 36) . However, CsA does not inhibit the transcription of immediate-early genes required for activation of T cells such as c-fos (33) . In addition, we show in this report that the blockage of TCR-mediated apoptosis by CsA does not interfere with the induction of Nur77 gene transcription, but it interferes with the activation of Nur77 target genes. Therefore, it is possible that the immediate signals delivered by TCR may not be different between apoptotic and proliferating cells. A further detailed study of how the DNA binding activity of Nur77 protein is regulated by CsA may provide insights into how apoptotic and proliferating T cells are regulated. It may also lead to a better understanding of how CsA leads to the induction of autoimmune diseases in certain cases.
